Mind Medicine Inc (NASDAQ: MNMD) Disappoints Wall Street With -3.04% Stock Price Loss

Mind Medicine Inc (NASDAQ:MNMD) has a beta value of 1.72 and has seen 0.63 million shares traded in the recent trading session. The company, currently valued at $188.67M, closed the recent trade at $6.70 per share which meant it lost -$0.21 on the day or -3.04% during that session. The MNMD stock price is -82.39% off its 52-week high price of $12.22 and 64.03% above the 52-week low of $2.41. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.94 million shares traded. The 3-month trading volume is 1.35 million shares.

The consensus among analysts is that Mind Medicine Inc (MNMD) is Buy stock at the moment, with a recommendation rating of 1.10. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.33.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Mind Medicine Inc (NASDAQ:MNMD) trade information

Sporting -3.04% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the MNMD stock price touched $6.70 or saw a rise of 14.65%. Year-to-date, Mind Medicine Inc shares have moved 83.06%, while the 5-day performance has seen it change -10.31%. Over the past 30 days, the shares of Mind Medicine Inc (NASDAQ:MNMD) have changed -10.19%. Short interest in the company has seen 9.24 million shares shorted with days to cover at 5.43.

Wall Street analysts have a consensus price target for the stock at $21, which means that the shares’ value could jump 68.1% from the levels at last check today. The projected low price target is $20.0 while the price target rests at a high of $22.0. In that case, then, we find that the latest price level in today’s session is -228.36% off the targeted high while a plunge would see the stock gain -198.51% from the levels at last check today.

Mind Medicine Inc (MNMD) estimates and forecasts

Figures show that Mind Medicine Inc shares have outperformed across the wider relevant industry. The company’s shares have gained 51.93% over the past 6 months, with this year growth rate of 22.54%, compared to 16.80% for the industry.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 2.29% over the past 5 years.

Mind Medicine Inc (NASDAQ:MNMD)’s Major holders

Insiders own 1.19% of the company shares, while shares held by institutions stand at 51.43% with a share float percentage of 52.05%. Investors are also buoyed by the number of investors in a company, with Mind Medicine Inc having a total of 180.0 institutions that hold shares in the company.